References
- Amer M. S. “Cyclic Adenosine Monophosphate and Hypertension in Rats,”. Science 1973; 179: 807
- Amer M. S., Doba N., Reis D. J. “Changes in Cyclic Nucleotide Metabolism in Aorta and Heart of Neurogenically Hypertensive Rats: Possible Trigger Mechanism of Hypertension,”. Proc. Natl. Acad. Sci. USA 1975; 72: 2135
- Axelrod J. “Catecholamines and Hypertension,”. Clin. Sci. Mol. Med. 1976; 51: 415s
- Brown B. L., Albano J. D. L., Ekins R. P., Sgherzil A. M., Tampion W. A Simple and Sensitive Saturation Method for the Measurement of Adenosine-3′:5′-Cyclic Monophosphate. Biochem. J. 1971; 121: 561
- Champlain J. D., Farley L., Cousineau D., Ameringen M-R. “Circulating Catecholamine Levels in Human and Experimental Hypertension,”. Circ. Res. 1976; 38: 109
- DeQuattro V., Miura Y., Lurvey A., Cosgrove M., Mendez R. “Increased Plasma Catecholamine Concentrations and Vas Deferens Norepinephrine Biosynthesis in Men with Elevated Blood Pressure,”. Circ. Res. 1975; 36: 118
- Gallant S. P., Duriseti L., Underwood S., Insel P. A. “Decreased Beta-Adrenergic Receptors on Polymorphonuclear Leukocytes after Adrenergic Therapy,”. N. Engl. J. Med. 1978; 299: 933
- Greenacre J. K., Conolly M. E. “Desensitization of Beta-Adrenoceptor of Lymphocytes from Normal Subjects and Patients with Phaechromacytoma: Studies In Vivo,”. Br. J. Clin. Pharmacol. 1978; 5: 191
- Greengard P. “Phosphorylated Proteins as Physiological Effectors,”. Science 1978; 199: 146
- Kafka M. S., Tallman J. F., Smith C. C., Costa J. L. “Alpha-Adrenergic Receptors on Human Platelets,”. Life Sci. 1977; 21: 1429
- Kafka M. S., van Kammen D. P., Bunney W. E., Jr. “Reduced Cyclic AMP Production in the Blood Platelets from Schizophrenic Patients,”. Am. J. Psychiat., in press
- Koch-Weser J. “Sympathetic Activity in Essential Hypertension,”. N. Engl. J. Med. 1973; 288: 627
- Lake C. R., Ziegler M. J., Coleman M. D., Kopin I. J. “Age-Adjusted Plasma Levels Are Similar in Nomotensive and Hypertensive Subjects,”. N. Engl. J. Med. 1977; 296: 208
- Lake C. R., Ziegler M. G., Kopin I. J. “Use of Plasma Norepinephrine for Evaluation of Sympathetic Neuronal Function in Man,”. Life Sci. 1976; 18: 1315
- Moss A., Scott G. “Hypertension: United States, 1974,”. Advance Data from Vital and Health Statistics, National Center for Health Statistics 1976; 2: 1
- Pedersen E. B., Christensen N. J. “Catecholamines in Plasma and Urine in Patients with Essential Hypertension Determined by Double Isotope Derivative Techniques,”. Acta Med. Scand. 1975; 198: 373
- Reis D. J., Doba N. “The Central Nervous System and Neurogenic Hypertension,”. Progress in Cardiovascular Diseases 1974; XVII: 51
- Reis D. J., Doba N., Amer M. S. “The Central Neural Regulation of Baroreceptors of Peripheral Catecholaminergic Mechanism,”. Frontiers in Catecholamine Research, S. Snyder, E. Usdin. Pergamon Press, London 1973; 883
- Schmid G., Hempel K., Heidland A. “Decreased cAMP Content of the Hypothalamus of Genetically Hypertensive Rats,”. Naunyn-Schmiedeberg's Arch. Pharmacol. 1978; 302: 341
- Sporn J. R., Hardin T. K., Wolfe B. B., Molinoff P. B. “Beta-Adrenergic Receptor Involvement in 6-Hydroxydopamine Induced Supersensitivity in Rat Cerebral Cortex,”. Science 1976; 194: 624
- Strittmayer W. J., Davis J. N., Lefkowitz R. J. “Alpha-Adrenergic Receptors in Rat Parotid Cells II. Desensitization of Receptor Binding Sites and Potassium Release,”. J. Biol. Chem. 1977; 252: 5478
- Tallman J. F., Smith C. C., Henneberry R. C. “Induction of Functional Beta-Adrenergic Receptors in HeLa Cells,”. Proc. Natl. Acad. Sci. USA 1977; 74: 873
- Triner L., Nahas G. G., Vulliemoz Y., Overweg N. I. A., Verosky M., Habif D. V., Ngai S. H. “Cyclic AMP and Smooth Muscle Function,”. N. Y. Acad. Sci. 1971; 185: 458
- Wilhelm M., DeStevens G. “Antihypertensive Agents,”. Prog. Drug Res. 1976; 20: 197
- Williams L. T., Snyderman R., Lefkowitz R. J. “Identification of Beta-Adrenergic Receptors in Human Lymphocytes by 3H-Alprenolol Binding,”. J. Clin. Invest. 1976; 57: 149